Shelanski Research Innovation Award in Pathology

Supported by gifts from the Ralph Abrams Fund (from Anatomy and Cell Biology) and the Herman Shelanski Memorial Fund, Shelanski Research Innovation Award in Pathology is designed to support the development of innovative research ideas and concepts contributed by fellows and residents within the Department of Pathology and Cell Biology in their research projects that further our understanding of mechanisms of biology and pathophysiology of disease.

The award provides up to $5,000 to defray the cost of supplies and services for research projects to be conducted during the fiscal year of the award.

Applications are accepted and evaluated each fiscal year on an open/rolling basis. Interested applicants may submit as research teams or individuals, a 3-4 page (no more than 3000 words) proposal (excluding references) including background, central hypothesis, detailed specific aims, and a discussion of the expected outcome, significance, novelty, impact, and possible anticipated pitfalls to the approach. Applicants must also submit their current CV and a letter of support from their mentor(s) that provides a statement describing their support for the research and how participation and successful completion of the proposed research will be important for the career development of the applicant(s). 

Once documents are received the application is reviewed and rated by a committee of faculty and staff. Final decision is made and applicant is advised if awarded.

So far, the following pathology fellows/residents have received this award: 

  • 2017 - Osama Al Dalahmah, for his proposal titled: Glial Heterogeneity in Health and Huntington’s Disease.
  • 2018 - Paul (Chun Chieh) Lin, for his proposal titled: Deciphering Multifactorial Genetic Contributions for Motor Neuron Development.
  • 2020 - Marie Smithgall, for her proposal titled: Investigation of Discrepant MMR IHC and MSI PCR Test Results for Gynecologic Cancers.
  • 2021 - Michael Miller, for his proposal titled: Rosette-forming Glioneuronal Tumors (RGNT) Are Rare Brain Tumors Primarily Seen in Children And Young Adults.
  • 2022 – Yu Sun, for her proposal titled: Dissecting IDH-mutant dependence and intratumor heterogeneity during astrocytoma progression.

Please address inquiries to